According to data made available by George Mason University's Mercatus Center and analyzed by Regulatory Focus, the number of regulatory requirements imposed by the US Food and Drug Administration (FDA) increased by 15% between the years 2000 and 2012.
This article is related to the Whitepaper: 21 CFR Part 11 Industry Overview - Ready for an FDA Inspection? To get the full details, please download your free copy.
Alexander Gaffney is a health policy professional who manages the regulatory intelligence group at RAPS, the leading global association of regulatory affairs professionals. He is also the lead writer for Regulatory Focus, a widely read publication covering the regulation of pharmaceuticals, medical devices, biotechnology products and the US Food and Drug Administration (FDA).